| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10918590 | Radiotherapy and Oncology | 2014 | 6 Pages |
Abstract
Given that HYPO is at least not inferior to CONV with a similar toxicity profile, the hypofractionation scheme used in this study can be offered to patients with T1-2 glottic carcinoma with potential advantages in terms of local control and a shortened overall treatment time.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Sung Ho Moon, Kwan Ho Cho, Eun Ji Chung, Chang Geol Lee, Kyu Chan Lee, Gyu-Young Chai, Ki Mun Kang, Jong Young Lee, Woong-Ki Chung, Woo Yoon Park, Jin Hee Kim,